Ibyerekeye-kanseri / kuvura / ivuriro-ibigeragezo / indwara / nyababyeyi-sarcoma / kuvura

From love.co
Simbukira kugendagenda Simbuka gushakisha
This page contains changes which are not marked for translation.

Kuvura Ibizamini bya Clinical kuri Uterine Sarcoma

Igeragezwa rya Clinical ni ubushakashatsi bwubushakashatsi burimo abantu. Igeragezwa rya clinique kururu rutonde ni ukuvura nyababyeyi sarcoma. Ibigeragezo byose kurutonde bishyigikiwe na NCI.

Amakuru yibanze ya NCI kubyerekeye ibizamini byamavuriro asobanura ubwoko nicyiciro cyibigeragezo nuburyo bikorwa. Igeragezwa rya Clinical rireba uburyo bushya bwo kwirinda, gutahura, cyangwa kuvura indwara. Urashobora gushaka gutekereza kubijyanye no kwitabira ikizamini cyamavuriro. Vugana na muganga wawe kugirango agufashe guhitamo niba umwe akubereye.

Ikigeragezo 1-5 cya 5

Nivolumab mu kuvura abarwayi bafite Kanseri ya Uterine Metastatike cyangwa Isubiramo

Iki cyiciro cya II cyikigereranyo cyiga uburyo nivolumab ikora neza mukuvura abarwayi ba kanseri yinkondo y'umura yakwirakwiriye ahandi mu mubiri (metastatike) cyangwa ikagaruka nyuma yigihe cyo gutera imbere (kugaruka). Immunotherapy hamwe na antibodiyite za monoclonal, nka nivolumab, irashobora gufasha umubiri wumubiri gutera kanseri, kandi irashobora kubangamira ubushobozi bwingirabuzimafatizo zikura no gukwirakwira.

Aho uherereye: ahantu 7

Amasomo Mugufi Vaginal Cuff Brachytherapy mukuvura abarwayi bafite kanseri yo mu cyiciro cya I-II

Iki cyiciro cya gatatu cyateganijwe cyiga amasomo magufi yigituba cuff brachytherapy kugirango harebwe uburyo ikora neza ugereranije nubuvuzi bwa vaginal cuff brachytherapy mu kuvura abarwayi bafite kanseri yo mu cyiciro cya I-II. Amasomo magufi ibyara cuff brachytherapy, bizwi kandi nkubuvuzi bwimbere bwimirasire yimbere, akoresha (mugihe gito) ibikoresho bya radioaktike bishyirwa mubibyimba cyangwa hafi yikibyimba mugice cyo hejuru yigituba kugirango bice selile.

Aho uherereye: ahantu 7

Isesengura ryihuse nigisubizo cyo gusuzuma imiti igabanya ubukana bwa Neoplastique mu Bibyimba Bidasanzwe (KANSERI NTIBISANZWE) Ikigeragezo: NTIBISANZWE 1 Nilotinib na Paclitaxel

Amavu n'amavuko: Abantu bafite kanseri zidasanzwe akenshi bafite uburyo buke bwo kuvura. Ibinyabuzima bya kanseri idasanzwe ntabwo byumvikana neza. Abashakashatsi bifuza kubona uburyo bwiza bwo kuvura kanseri. Bashaka gupima ibiyobyabwenge 2, byafashwe ukwe, bifasha abantu barwaye kanseri idasanzwe. Bashaka kureba niba iyi miti hamwe ishobora gutuma kanseri zidasanzwe zigabanuka cyangwa guhagarika gukura. Intego: Kumenya niba nilotinib na paclitaxel bizagirira akamaro abantu barwaye kanseri idasanzwe. Abemerewe: Abantu bafite imyaka 18 nayirenga bafite kanseri idasanzwe, yateye imbere yateye imbere nyuma yo kuvurwa bisanzwe, cyangwa kubwo kutavura neza. Igishushanyo: Abitabiriye amahugurwa bazerekanwa n'amateka y'ubuvuzi n'ikizamini cy'umubiri. Bazokwipimisha amaraso ninkari. Bazokwipimisha inda nibikenewe. Bazagira electrocardiogram yo gusuzuma imitima yabo. Bazaba bafite amashusho yo gupima ibibyimba byabo. Abitabiriye amahugurwa bazasubiramo ibizamini byo gusuzuma mugihe cyo kwiga. Abitabiriye amahugurwa bazahabwa nilotinib na paclitaxel. Ibiyobyabwenge bitangwa muminsi 28. Nilotinib ni capsule ifatwa numunwa kabiri kumunsi. Paclitaxel izahabwa imitsi n'umurongo wa peripheri cyangwa umurongo wo hagati rimwe mucyumweru ibyumweru 3 byambere bya buri cyiciro. Abitabiriye amahugurwa bazakomeza kwandika imiti. Bazakurikirana igihe bafashe ibiyobyabwenge byo kwiga n'ingaruka zose bashobora kugira. Abitabiriye amahugurwa barashobora kugira ibibyimba bidasanzwe. Abitabiriye amahugurwa barashobora kuguma ku bushakashatsi kugeza igihe indwara yabo izaba mbi cyangwa bakagira ingaruka zitihanganirwa. Abitabiriye amahugurwa bazajya bakurikirana terefone nyuma yiminsi 30 nyuma yo gufata igipimo cya nyuma cyibiyobyabwenge. Abitabiriye amahugurwa bazahabwa nilotinib na paclitaxel. Ibiyobyabwenge bitangwa muminsi 28. Nilotinib ni capsule ifatwa numunwa kabiri kumunsi. Paclitaxel izahabwa imitsi n'umurongo wa peripheri cyangwa umurongo wo hagati rimwe mucyumweru ibyumweru 3 byambere bya buri cyiciro. Abitabiriye amahugurwa bazakomeza kwandika imiti. Bazakurikirana igihe bafashe ibiyobyabwenge byo kwiga n'ingaruka zose bashobora kugira. Abitabiriye amahugurwa barashobora kugira ibibyimba bidasanzwe. Abitabiriye amahugurwa barashobora kuguma ku bushakashatsi kugeza igihe indwara yabo izaba mbi cyangwa bakagira ingaruka zitihanganirwa. Abitabiriye amahugurwa bazajya bakurikirana terefone nyuma yiminsi 30 nyuma yo gufata igipimo cya nyuma cyibiyobyabwenge. Abitabiriye amahugurwa bazahabwa nilotinib na paclitaxel. Ibiyobyabwenge bitangwa muminsi 28. Nilotinib ni capsule ifatwa numunwa kabiri kumunsi. Paclitaxel izahabwa imitsi n'umurongo wa peripheri cyangwa umurongo wo hagati rimwe mucyumweru ibyumweru 3 byambere bya buri cyiciro. Abitabiriye amahugurwa bazakomeza kwandika imiti. Bazakurikirana igihe bafashe ibiyobyabwenge byo kwiga n'ingaruka zose bashobora kugira. Abitabiriye amahugurwa barashobora kugira ibibyimba bidasanzwe. Abitabiriye amahugurwa barashobora kuguma ku bushakashatsi kugeza igihe indwara yabo izaba mbi cyangwa bakagira ingaruka zitihanganirwa. Abitabiriye amahugurwa bazajya bakurikirana terefone nyuma yiminsi 30 nyuma yo gufata igipimo cya nyuma cyibiyobyabwenge. Paclitaxel izahabwa imitsi n'umurongo wa peripheri cyangwa umurongo wo hagati rimwe mucyumweru ibyumweru 3 byambere bya buri cyiciro. Abitabiriye amahugurwa bazakomeza kwandika imiti. Bazakurikirana igihe bafashe ibiyobyabwenge byo kwiga n'ingaruka zose bashobora kugira. Abitabiriye amahugurwa barashobora kugira ibibyimba bidasanzwe. Abitabiriye amahugurwa barashobora kuguma ku bushakashatsi kugeza igihe indwara yabo izaba mbi cyangwa bakagira ingaruka zitihanganirwa. Abitabiriye amahugurwa bazajya bakurikirana terefone nyuma yiminsi 30 nyuma yo gufata igipimo cya nyuma cyibiyobyabwenge. Paclitaxel izahabwa imitsi n'umurongo wa peripheri cyangwa umurongo wo hagati rimwe mucyumweru ibyumweru 3 byambere bya buri cyiciro. Abitabiriye amahugurwa bazakomeza kwandika imiti. Bazakurikirana igihe bafashe ibiyobyabwenge byo kwiga n'ingaruka zose bashobora kugira. Abitabiriye amahugurwa barashobora kugira ibibyimba bidasanzwe. Abitabiriye amahugurwa barashobora kuguma ku bushakashatsi kugeza igihe indwara yabo izaba mbi cyangwa bakagira ingaruka zitihanganirwa. Abitabiriye amahugurwa bazajya bakurikirana terefone nyuma yiminsi 30 nyuma yo gufata igipimo cya nyuma cyibiyobyabwenge.

Aho biherereye: Ikigo cyigihugu cyita ku buzima Clinical Centre, Bethesda, Maryland

Cabozantinib na Temozolomide yo kuvura Leiomyosarcoma idashobora gukemurwa cyangwa Metastatike cyangwa Ibindi Byoroshye Tissue Sarcoma

Iki cyiciro cya II cyigeragezwa cyiga uburyo cabozantinib na temozolomide bikora neza mukuvura abarwayi barwaye leiomyosarcoma cyangwa izindi nyama zoroshye za sarcoma zidashobora gukurwaho no kubagwa (bidashoboka) cyangwa zikwirakwira ahandi mu mubiri (metastatike). Cabozantinib irashobora guhagarika imikurire ya selile yibibyimba ihagarika zimwe mu misemburo ikenewe kugirango imikurire ikure. Ibiyobyabwenge bikoreshwa muri chimiotherapie, nka temozolomide, bikora muburyo butandukanye bwo guhagarika imikurire ya selile yibibyimba, haba mukwica selile, kubabuza gutandukana, cyangwa kubabuza gukwirakwira. Gutanga cabozantinib na temozolomide birashobora gukora neza kurenza umwe wenyine mu kuvura abarwayi barwaye leiomyosarcoma cyangwa izindi nyama zoroshye sarcoma. Cabozantinib nibiyobyabwenge byiperereza,

Aho uherereye: ahantu 7

Doxorubicin, AGEN1884, na AGEN2034 yo kuvura Tissue Yoroheje cyangwa Metastatike Yoroheje Tissue Sarcoma

Iki cyiciro cya II cyikigereranyo cyiga uburyo doxorubicin ifatanije na AGEN1884 na AGEN2034 ikora mukuvura abarwayi bafite sarcoma yoroheje yoroheje yakwirakwiriye ahandi mumubiri (yateye imbere cyangwa metastatike). Ibiyobyabwenge bikoreshwa muri chimiotherapie, nka doxorubicin, bikora muburyo butandukanye bwo guhagarika imikurire ya selile yibibyimba, haba mukwica selile, kubabuza gutandukana, cyangwa kubabuza gukwirakwira. Immunotherapy hamwe na antibodiyite za monoclonal, nka AGEN1884 na AGEN2034, birashobora gufasha umubiri wumubiri kwibasira kanseri, kandi bishobora kubangamira ubushobozi bwingirabuzimafatizo yibibyimba gukura no gukwirakwira. Gutanga doxorubicin, AGEN1884, na AGEN2034 birashobora gukora neza mukuvura abarwayi bafite sarcoma yoroheje yoroheje ugereranije na doxorubicine yonyine.

Aho uherereye: ' Kaminuza ya Kolorado, Denver, Kolorado


Ongeraho igitekerezo cyawe
urukundo.co yakira ibitekerezo byose . Niba udashaka kumenyekana, iyandikishe cyangwa winjire . Nubuntu.